
Coravog 0.2mg Tablet
Marketer
Arlak Biotech Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Coravog 0.2mg Tablet
Diabetol 0.2mg tablets manage type 2 diabetes mellitus by regulating postprandial hyperglycemia. This medication is prescribed when dietary modifications and other similar treatments prove insufficient in controlling elevated blood glucose. Diabetol 0.2mg tablets should be administered immediately prior to meals; dosage and frequency are determined individually by your physician to optimize glycemic control. Discontinuing treatment abruptly is inadvisable; cessation may elevate blood sugar, increasing the risk of serious complications like nephropathy and visual impairment. This medication forms part of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported side effects include abdominal discomfort, flatulence, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While Diabetol 0.2mg tablets themselves do not induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Treatment for hypoglycemic episodes requires simple glucose; sucrose is ineffective. Inform your physician of any hepatic or renal dysfunction before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Comprehensive disclosure of all other medications is crucial for safe usage. Limit alcohol consumption to minimize the hypoglycemic risk.
Primary Ingredients of Coravog 0.2mg Tablet
No text provided. Please provide the text you wish to be rewritten.
Uses of Coravog 0.2mg Tablet
Managing Type 2 Diabetes
Major Benefits of Coravog 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Coravog 0.2mg Tablet on an empty stomach.
Common Side effects of Coravog 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Coravog 0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. The Coravog 0.2mg Tablet should be taken on an empty stomach.
How Coravog 0.2mg Tablet works:
Coravog 0.2mg tablets are used to manage diabetes. Their mechanism involves blocking enzymes in the gut that digest complex carbohydrates. This action helps to keep post-meal blood sugar increases within a healthier range.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Coravog 0.2mg Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
The medication Coravog 0.2mg Tablet is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nonetheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Coravog 0.2mg tablets safely. Available human data indicates minimal infant risk from the medication.
DrivingSAFE
Driving ability is typically unaffected by Coravog 0.2mg Tablets.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Coravog 0.2mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Coravog 0.2mg tablets cautiously. Dosage modification for Coravog 0.2mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Coravog 0.2mg Tablet :
Omit any missed Coravog 0.2mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Coravog 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Category | Alpha-glucosidase inhibitors |
